Ypsomed Company

Ypsomed is a company that specializes in developing and manufacturing injection and infusion systems for self-medication, particularly for diabetes patients. They have over 30 years of experience and are known for their innovation and technology. Ypsomed is a preferred partner for pharmaceutical and biotech companies for the supply of injection pens, autoinjectors, and infusion systems. They sell their products under the brands mylife Diabetescare and YDS Ypsomed Delivery Systems. Ypsomed is headquartered in Burgdorf, Switzerland, and has a global network of manufacturing sites, subsidiaries, and distributors. The company employs around 1400 people.


Invests into

Funding Status: IPO
Industry: Medical Technology
Estimated Revenue: $100M to $500M
Headquarters: Burgdorf
Employee Number: 1001-5000
Founded Date: 2003